1. Home
  2. CPIX vs BENF Comparison

CPIX vs BENF Comparison

Compare CPIX & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.08

Market Cap

73.6M

Sector

Health Care

ML Signal

N/A

Logo Beneficient

BENF

Beneficient

N/A

Current Price

$3.79

Market Cap

66.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
BENF
Founded
1999
2003
Country
United States
United States
Employees
N/A
55
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
66.2M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
BENF
Price
$3.08
$3.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
137.3K
523.1K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$30.01
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$0.22
52 Week High
$6.27
$9.96

Technical Indicators

Market Signals
Indicator
CPIX
BENF
Relative Strength Index (RSI) 33.13 42.70
Support Level $2.78 $0.38
Resistance Level $3.80 $4.99
Average True Range (ATR) 0.31 0.43
MACD -0.13 -0.04
Stochastic Oscillator 3.00 32.37

Price Performance

Historical Comparison
CPIX
BENF

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and a financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

Share on Social Networks: